News 06.11.2023 Abionic and Lascco partner with Fapon for sepsis diagnosis in China Biopôle companies Abionic and Lascco team up with Fapon to harness a groundbreaking biomarker for sepsis detection, enhancing early diagnosis cap...
News 06.11.2023 Vaud-based LAGOSTA and global giant Merck collaborate on chitosan distribution Biotech company LAGOSTA has announced a collaboration with Merck. The partnership aims to facilitate the distribution of LAGOSTA's superior chito...
最新 09.11.2023 瑞士Abionic和Lascco公司与菲鹏生物合作,助力中国医生诊断脓毒症 位于洛桑Biopôle生命科学园区的Abionic和Lascco公司,与中国菲鹏生物合作,利用突破性的生物标志物进行脓毒症检测,增强早期诊断能力。
Analisi 22.03.2021 Marketing digitale B2B in China Il panorama digitale in Cina è unico e in rapida evoluzione, molto diverso da quello europeo. Per scoprire come se la cavano le aziende svizzere ...
Analyse 22.03.2021 Digitales B2B-Marketing in China Die digitale Landschaft in China ist einzigartig und in rasanter Entwicklung, ganz anders als in Europa. Um herauszufinden, wo Schweizer Unterneh...
News 07.06.2023 Genedata expanding its user network The Japanese biopharmaceutical firm Ajinomoto is to use the Genedata solution to accelerate its drug development processes at its site in South K...
Analysis 22.03.2021 B2B Digital Marketing in China The digital landscape in China is unique and fast-evolving, way different than in Europe. In order to find out how the Swiss companies in China a...
Aktuell 07.06.2023 Genedata weitet Netz seiner Nutzer aus Das japanische Biopharma-Unternehmen Ajinomoto setzt die Lösung von Genedata zur Beschleunigung seiner Medikamentenentwicklung künftig auch an se...
News 23.02.2023 Xeltis raises 32 million euros The medtech firm Xeltis has raised a total of 32 million euros after successfully closing a financing round. Xeltis has also concluded a licensin...
Aktuell 23.02.2023 Xeltis sammelt 32 Millionen Euro ein Das Medtech-Unternehmen Xeltis hat in einer Finanzierungsrunde 32 Millionen Euro eingenommen. Ausserdem hat Xeltis mit Grand Pharma eine Lizenzve...
Exporteure im Fokus 27.06.2022 Unternehmen profitieren vom Freihandelsabkommen Schweiz-China Als einziges kontinentaleuropäisches Land verfügt die Schweiz seit dem 1. Juli 2014 über ein umfassendes Freihandelsabkommen mit China. Im fünfte...
News 23.11.2022 Geneva biopharma ObsEva sells its Ebopiprant license for up to USD 113 million Women's and reproductive health specialist ObsEva has announced the sale of its license for ebopiprant to California-based biotech company Xoma f...
Focus on exporters 27.09.2018 Companies benefit from free trade agreement between Switzerland and China Since 1 July 2014, Switzerland has been the only continental European country to have signed a comprehensive free trade agreement (FTA) with Chin...
Analyse 22.03.2021 Marketing digital B2B en Chine En constante évolution, le paysage du numérique chinois est unique en son genre et radicalement différent de son équivalent européen. Afin de sav...
Focus exportateurs 08.01.2021 Les entreprises tirent avantage de l’accord de libre-échange Suisse-Chine La Suisse est le seul état d’Europe continentale à disposer, depuis le 1er juillet 2014, d’un accord bilatéral de libre-échange de grande ampleur...
Esportatori in primo pian... 09.10.2018 Le aziende usufruiscono dell’accordo di libero scambio tra Svizzera e Cina La Svizzera è l’unico Paese dell’Europa continentale, che dal 1° luglio 2014 dispone di un vasto accordo di libero scambio con la Cina. Al quinto...
News 27.04.2018 Five reasons to register for the Aussenwirtschaftsforum now The Switzerland Global Enterprise Aussenwirtschaftsforum is the annual meeting of the Swiss export economy. Why is this year's event unmissable f...